The F.D.A. tells Johnson & Johnson to throw out about 60 million doses made at troubled plant

WASHINGTON — After weeks of review of a troubled Baltimore factory, federal regulators have decided that about 60 million doses of the Johnson & Johnson coronavirus vaccine produced there must be discarded because of possible contamination, according to people familiar with the situation.

The Food and Drug Administration plans to allow about 10 million doses to be distributed in the United States or sent to other countries, but with a warning that regulators cannot guarantee that Emergent BioSolutions, the company that operates the plant, followed good manufacturing practices. The agency has not yet decided whether Emergent can reopen the factory, which has been closed for two months because of regulatory concerns, the people said.

For weeks the F.D.A. has been trying to figure out what to do about at least 170 million doses of vaccine that were left in limbo after the discovery of a major production mishap involving two vaccines manufactured at the site.

Moderna asks FDA to clear COVID-19 vaccine for adolescents Moderna on Thursday said it has filed a request with the Food and Drug Administration (FDA) to use its coronavirus vaccine in adolescents as young as 12 years old. Nathaniel Weixel TheHill

Moderna on Thursday said it has filed a request with the Food and Drug Administration (FDA) to use its coronavirus vaccine in adolescents as young as 12 years old.

The U.S. is expected to provide 500 million Pfizer-BioNTech doses to 100 nations over the next year

The White House has reached an agreement with Pfizer and BioNTech to provide 500 million doses of coronavirus vaccine to about 100 countries over the next year, a pact that President Biden plans to announce as early as Thursday, according to multiple people familiar with the plan.

Under intense pressure to do more to address the global vaccine shortage and the disparities in vaccination between rich and poor nations, the president hinted at the plan Wednesday morning, when he was asked if he had a vaccination strategy for the world.